Xavier Liem
Radiotherapy — Centre Oscar Lambret, France
Xavier Liem
LeadR Profile
Radiotherapy
Subspecialties: Oncology - Otolaryngology - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 82
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Evaluation of the nutritional and digestive impact of irradiation in nasopharyngeal cancers: the French multicenter retrospective DRAKAR study. radiotherapy, hospitalization, malnutrition, neoplasms, nasopharyngeal neoplasms, therapeutics, enteral nutrition | Clin Transl Radiat Oncol | 2026 | 0 |
| Defining the Role of SABR in Head and Neck Cancer: Results from a Multi-institutional Delphi Consensus. neoplasms, multiple chronic conditions, radiobiology, re-irradiation, head and neck neoplasms, therapeutics | Int J Radiat Oncol Biol Phys | 2026 | 0 |
| Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial. radiotherapy, cells, carcinoma, squamous cell, neoplasms, clinical medicine, necrosis, beds, therapeutics, non-randomized controlled trials as topic, mouth | JAMA Netw Open | 2025 | 0 |
| Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical Trial. radiotherapy, comorbidity, safety, cetuximab, progression-free survival, nanoparticles, neoplasms, squamous cell carcinoma of head and neck, head and neck neoplasms, therapeutics, non-randomized controlled trials as topic, wounds and injuries | JAMA Otolaryngol Head Neck Surg | 2026 | 0 |
| HDR and PDR brachytherapy for facial nonmelanoma skin cancer: Outcome and toxicity assessment for 155 patients. skin, cells, carcinoma, squamous cell, brachytherapy, neoplasms, wounds and injuries, skin neoplasms | Brachytherapy | 2025 | 0 |
Clinical Studies 17
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study of JNJ 90301900 in Combination with Concurrent Chemoradiation Therapy in LA HNSCC 2025-522914-22-00 — squamous cell carcinoma of head and neck, therapeutics | Phase 1 | Recruiting | 2026 |
| Pan lesions SBRT combined with lymphocyte support through ATRA driven blockade of MDSC in patients with oligometastatic solid cancer (LySATRA) 2022-500680-13-00 — myeloid-derived suppressor cells, lymphocytes, neoplasms, wounds and injuries | Phase 1/Phase 2 | Recruiting | 2024 |
| LYSARI LYmphocyte Sparing And Radio Immunotherapy in Head and neck carcinoma A multicenter randomised 2 2 factorial design comparing standard to reduced target volume radiotherapy with or without all trans retinoic acid (ATRA) in patients with lateralised oropharyngeal laryngeal and hypopharyngeal squamous cell carcinoma 2022-501315-13-00 — radiotherapy, cells, lymphocytes, carcinoma, squamous cell, immunotherapy, tretinoin, carcinoma, head, neck | Phase 3 | Recruiting | 2025 |
| SPECT CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer NCT07241273 — oropharyngeal neoplasms, radiotherapy, cells, drainage, quality of life, lymph nodes, carcinoma, squamous cell, single photon emission computed tomography computed tomography, neoplasms, drug-related side effects and adverse reactions, squamous cell carcinoma of head and neck, lymph, tomography, emission-computed, single-photon, head and neck neoplasms, therapeutics, carcinoma, head, neck | N/A | Not yet recruiting | 2026 |
| Lymphocyte Sparing And Radio Immunotherapy in Head and Neck Carcinoma NCT06706401 — oropharyngeal neoplasms, radiotherapy, cells, cetuximab, larynx, lymphocytes, carcinoma, squamous cell, laryngeal neoplasms, neoplasms, hypopharyngeal neoplasms, hypopharynx, drug therapy, immunotherapy, squamous cell carcinoma of head and neck, head and neck neoplasms, therapeutics, oropharynx, tretinoin, chemotherapy, therapy delivery, carcinoma, head, neck | Phase 3 | Recruiting | 2025 |
LeadR Networks
Main global connection map